Strides Pharma names Nandini Matiyani Global Head of HR

Strides Pharma Science has appointed Nandini Matiyani as Executive Vice President and Global Head of Human Resources, strengthening the company’s leadership bench as it scales its global operations.

In a post on LinkedIn, Matiyani said she was “embarking on a new journey” with Strides and will lead the global HR function across the pharmaceutical group’s international footprint. She thanked Chairman Arun Kumar, Managing Director and Group CEO Badri Srinivasan, and the board for their confidence in her appointment.

Matiyani brings more than 20 years of experience in people strategy, cultural transformation and HR leadership across multinational and publicly listed organisations. She said her focus at Strides will be on strengthening capabilities, reinforcing culture and supporting the company’s ambition to deliver “better and fairer healthcare” through agility, innovation and meaningful people practices.

Strides, established in 1990 and headquartered in Bengaluru, operates in more than 100 countries, supplying regulated markets, donor-funded channels and its “in Africa for Africa” business. The company manufactures complex pharmaceutical products from sites in India, Italy, Kenya and the United States.

Matiyani said she looks forward to working with teams across geographies to build talent strength and organisational capacity as Strides accelerates its global agenda. Her appointment underscores the company’s focus on leadership development and culture building as it competes in highly regulated and cost-sensitive markets.

The company has not announced further organisational changes, but the expanded HR leadership role signals a sharper emphasis on people systems and capability building as Strides targets growth across key markets.

Related Posts

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Hyderabad – A groundbreaking study by the Indian Council of Medical Research’s National Institute of Nutrition (ICMR-NIN) has established a clear association between micronutrient deficiencies and elevated dementia risk among Indian…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Drug companies directed to step up vigil on adverse reactions

Drug companies directed to step up vigil on adverse reactions